Herbalists' perception of risks involving commonly sold medicinal plants in italy

Complementary Therapies in Medicine

Volumn 22, Issue 1, 2014, Pages 81-86

  Gallo, Eugenia ^a,b   Lucenteforte, Ersilia ^a   Firenzuoli, Fabio ^b   Menniti Ippolito, Francesca ^c   Maggini, Valentina ^a   Pugi, Alessandra ^a   Mascherini, Vittorio ^b   Gori, Luigi ^b   Mugelli, Alessandro ^a   Vannacci, Alfredo ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Herbalists; Medicinal plants; Risk perception; Survey; VAS

Indexed keywords

HERBALISTS; MEDICINAL PLANTS; RISK PERCEPTION; SURVEY; VAS;

FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PERSONNEL; HUMANS; ITALY; MALE; PERCEPTION; PHYTOTHERAPY; PLANTS, MEDICINAL; QUESTIONNAIRES; RISK; VISUAL ANALOG SCALE;

EID: 84894254061     PISSN: 09652299     EISSN: 18736963     Source Type: Journal    
DOI: 10.1016/j.ctim.2013.12.002     Document Type: Article

References (37)

1. Tindle H.A., Davis R.B., Phillips R.S., Eisenberg D.M. Trends in use of complementary and alternative medicine by US adults: 1997-2002. Altern Ther Health Med 2005, 11:42-49.
2. Ernst E., White A. The BBC survey of complementary medicine use in the UK. Complement Ther Med 2000, 8:32-36.
3. MacLennan A.H., Wilson D.H., Taylor A.W. Prevalence and cost of alternative medicine in Australia. Lancet 1996, 347:569-573.
4. Menniti-Ippolito F., Gargiulo L., Bologna E., Forcella E., Raschetti R. Use of unconventional medicine in Italy: a nation-wide survey. Eur J Clin Pharmacol 2002, 58:61-64.
5. Zaffani S., Cuzzolin L., Benoni G. Herbal products: behaviors and beliefs among Italian women. Pharmacoepidemiol Drug Saf 2006, 15:354-359.
6. Fugh-Berman A. Herb-drug interactions. Lancet 2000, 355:134-138.
7. Barnes J. Pharmacovigilance of herbal medicines: a UK perspective. Drug Saf 2003, 26:829-851.
8. Lapi F., Vannacci A., Moschini M., Cipollini F., Morsuillo M., Gallo E., et al. Use, attitudes and knowledge of complementary and alternative drugs (CADs) among pregnant women: a preliminary survey in Tuscany. Evid Based Complement Alternat Med 2010, 7:477-486.
9. Lucenteforte E., Gallo E., Pugi A., Giommoni F., Paoletti A., Vietri M., et al. Complementary and alternative drugs use among preoperative patients: a cross-sectional study in Italy. Evid Based Complement Alternat Med 2012, 2012:527238.
10. Yang A.K., He S.M., Liu L., Liu J.P., Wei M.Q., Zhou S.F. Herbal interactions with anticancer drugs: mechanistic and clinical considerations. Curr Med Chem 2010, 17:1635-1678.
11. Kwan D., Hirschkorn K., Boon H. U.S. and Canadian pharmacists' attitudes, knowledge, and professional practice behaviors toward dietary supplements: a systematic review. BMC Complement Altern Med 2006, 6:31.
12. Kemper K.J., Amata-Kynvi A., Dvorkin L., Whelan J.S., Woolf A., Samuels R.C., et al. Herbs and other dietary supplements: healthcare professionals' knowledge, attitudes, and practices. Altern Ther Health Med 2003, 9:42-49.
13. Bushett N.J., Dickson-Swift V.A., Willis J.A., Wood P. Rural Australian community pharmacists' views on complementary and alternative medicine: a pilot study. BMC Complement Altern Med 2011, 11:103.
14. Cuzzolin L., Benoni G. Attitudes and knowledge toward natural products safety in the pharmacy setting: an Italian study. Phytother Res 2009, 23:1018-1023.
15. Borrelli F., Capasnso R., Izzo A.A. Garlic (Allium sativum L.): adverse effects and drug interactions in humans. Mol Nutr Food Res 2007, 51:1386-1397.
16. Sumiyoshi H. New pharmacological activities of garlic and its constituents. Nihon Yakurigaku Zasshi 1997, 110(Suppl. 1):93P-97P.
17. Morrow D.M., Rapaport M.J., Strick R.A. Hypersensitivity to aloe. Arch Dermatol 1980, 116:1064-1065.
18. Medical Economics Company PDR for herbal medicines 2007, Medical Economics Company, Montvale, NJ.
19. Firenzuoli F. Fitoterapia. Guida all'uso clinico delle piante medicinali 2008, Elsevier, Milano. IV ed.
20. Huntley A., Ernst E. A systematic review of the safety of black cohosh. Menopause 2003, 10:58-64.
21. Capasso F., Grandolini G., Izzo A.A. Fitoterapia. Impiego razionale delle droghe vegetali 2006, Springer.
22. Jordan S., Murty M., Pilon K. Products containing bitter orange or synephrine: suspected cardiovascular adverse reactions. CMAJ 2004, 171:993-994.
23. Nykamp D.L., Fackih M.N., Compton A.L. Possible association of acute lateral-wall myocardial infarction and bitter orange supplement. Ann Pharmacother 2004, 38:812-816.
24. Burke J., Seda G., Allen D., Knee T.S. A case of severe exercise-induced rhabdomyolysis associated with a weight-loss dietary supplement. Mil Med 2007, 172:656-658.
25. Huntley A.L., Thompson Coon J., Ernst E. The safety of herbal medicinal products derived from Echinacea species: a systematic review. Drug Saf 2005, 28:387-400.
26. Schafer H.L., Schafer H., Schneider W., Elstner E.F. Sedative action of extract combinations of Eschscholtzia californica and Corydalis cava. Arzneimittelforschung 1995, 45:124-126.
27. Banz Eschscholtzia californica (Kalifornischer goldmohn) 1991, European Committee Monograph No. 178.
28. Vlachojannis J., Roufogalis B.D., Chrubasik S. Systematic review on the safety of Harpagophytum preparations for osteoarthritic and low back pain. Phytother Res 2008, 22:149-152.
29. Ryu S.J., Chien Y.Y. Ginseng-associated cerebral arteritis. Neurology 1995, 45:829-830.
30. Bahrke M.S., Morgan W.P. Evaluation of the ergogenic properties of ginseng. Sports Med 1994, 18:229-248.
31. Siegel R.K. Ginseng abuse syndrome problems with the panacea. JAMA 1979, 241:1614-1615.
32. Vazquez I., Aguera-Ortiz L.F. Herbal products and serious side effects: a case of ginseng-induced manic episode. Acta Psychiatr Scand 2002, 105:76-77. discussion 77-78.
33. Gonzalez-Seijo J.C., Ramos Y.M., Lastra I. Manic episode and ginseng: report of a possible case. J Clin Psychopharmacol 1995, 15:447-448.
34. Engelberg D., McCutcheon A., Wiseman S. A case of ginseng-induced mania. J Clin Psychopharmacol 2001, 21:535-537.
35. Hegyi E., Suchy V., Nagy M. Propolis allergy. Hautarzt 1990, 41:675-679.
36. Menniti-Ippolito F., Mazzanti G., Vitalone A., Firenzuoli F., Santuccio C. Surveillance of suspected adverse reactions to natural health products: the case of propolis. Drug Saf 2008, 31:419-423.
37. Propolis: hypersensitivity reactions. Prescrire Int 2010, 19:170.